<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9280">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05701410</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-117-22</org_study_id>
    <nct_id>NCT05701410</nct_id>
  </id_info>
  <brief_title>Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis.</brief_title>
  <acronym>CASS-I</acronym>
  <official_title>Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steen Hvitfeldt Poulsen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarhus University Hospital Skejby</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates the prevalence of cardiac amyloidosis among patients with a history of&#xD;
      lumbar spinal stenosis within the last ten years in the region of central Denmark.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2023</start_date>
  <completion_date type="Anticipated">April 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of cardiac amyloidosis</measure>
    <time_frame>1 year</time_frame>
    <description>DPD scintigraphy with a Perugini Grade 2 og higher.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cardiac Amyloidosis</condition>
  <condition>Spinal Stenosis</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with a history of lumbar spinal stenosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>DPD scintigraphy</intervention_name>
    <description>Bone tracer scintigraphy, diagnostic for transthyretin amyloidosis.</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  History of lumbar spinal stenosis.&#xD;
&#xD;
          -  Age &gt; 60 years at the time of spinal stenosis surgery.&#xD;
&#xD;
          -  Written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known amyloidosis&#xD;
&#xD;
          -  Myelomatosis&#xD;
&#xD;
          -  Monoclonal gammopathy of unknown origin, MGUS&#xD;
&#xD;
          -  Morbus Waldenstr√∏m&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bertil Ladefoged, MD</last_name>
    <phone>+45 40927245</phone>
    <email>berlad@rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiology, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertil Ladefoged</last_name>
      <phone>40927245</phone>
      <email>berlad@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 16, 2023</study_first_submitted>
  <study_first_submitted_qc>January 26, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2023</study_first_posted>
  <last_update_submitted>January 26, 2023</last_update_submitted>
  <last_update_submitted_qc>January 26, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital Skejby</investigator_affiliation>
    <investigator_full_name>Steen Hvitfeldt Poulsen</investigator_full_name>
    <investigator_title>Professor, PhD, DMSci</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

